Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain

Sponsor
Island Health (Other)
Overall Status
Completed
CT.gov ID
NCT05982483
Collaborator
(none)
30
1
2
40.3
0.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the Erector Spinae plane (ESP) block, a nerve block, to usual care in emergency department patients with back pain. The main question it aims to answer:

Is the ESP block superior to usual care in the treatment of back pain in the emergency department? Participants will be randomly assigned to the ESP or the usual care group. Pain improvement at the time of emergency department discharge will be compared.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Erector Spinae plane block using 20 ml of bupivicaine 0.25%
  • Drug: Usual care
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
Participants in both cohorts had pink chlorhexidine skin prep and a dressing applied to the back. Research team members performing the telephone follow-up were blinded to treatment allocation.
Primary Purpose:
Treatment
Official Title:
Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain: A Randomized Controlled Trial
Actual Study Start Date :
Sep 8, 2019
Actual Primary Completion Date :
Jan 16, 2023
Actual Study Completion Date :
Jan 16, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: ESP cohort

Randomized to receive the ultrasound-guided ESP block.

Procedure: Erector Spinae plane block using 20 ml of bupivicaine 0.25%
Utilizing the in line approach, a 22 gauge 3.5" spinal needle was guided the the tip of the transverse process corresponding to the area of maximal tenderness or central to the reported area of spasm. 1% lidocaine with epinephrine was used for skin anaesthesia and for hydro-localization of the needle tip on approach to the tip of the transverse process. Once the needle tip made contact with the transverse process, 2-3 ml of 1% lidocaine with epinephrine was injected to open the ESP plane. If there was no reported tachycardia after approximately 45 seconds, 20 ml of 0.25% bupivicaine was injected into the ESP plane.

Active Comparator: Usual care cohort

Randomized to usual care as dictated by the treating emergency physician

Drug: Usual care
Analgesia as dictated by the treating emergency physician

Outcome Measures

Primary Outcome Measures

  1. Numeric Verbal Pain Score (NVPS) reduction at emergency department discharge [Numeric verbal pain score (NVPS) at time of randomization compared with NVPS at time of discharge from the emergency department up to 24 hours after randomization.]

    The NVPS is an 11-point verbal pain scale from 0 to 10 with 0 representing no pain and 10 the worst pain imaginable.

Secondary Outcome Measures

  1. Number of patients requiring post randomization Emergency department (ED) opiate analgesia analgesia use [Time of randomization to time of ED discharge up to 24 hours after randomization.]

    Opiate medication dose and route of administration was recorded

  2. Emergency department (ED) length of stay. [Time of ED triage to time of ED discharge up to 24 hours after triage.]

    Time spent in the emergency department.

  3. Brief Pain Inventory (BPI) score reduction from baseline [Time of randomization compared to 1 day, 1 week, 1 month, and 3 months post Emergency department visit]

    The Brief Pain Inventory (BPI) is widely used to measure a patients' pain intensity and interference the pain has on daily function measured in 7 categories: mood, work, general activity, walking, relationships, enjoyment of life, and sleep. The patient rates each of these on a scale from 0-10with 0 representing no interference and 10 complete interference in that aspect of life. The initial BPI was recorded at time of randomization and subsequent BPI's recorded by telephone follow-up at predetermined time intervals

  4. Number of patients requiring post Emergency department discharge opiate analgesia use [Date of randomization to 1 day after randomization, 1 day after randomization to 1 week after randomization, 1week after randomization to 1 month after randomization, 1 month after randomization to 3 months after randomization.]

    During telephone follow up, patients were asked if there was any opiate analgesia used during the pre-determined time period.

  5. Post Emergency department (ED) discharge Numeric Verbal Pain Score (NVPS) [1 day after randomization, 1 week after randomization, 1 month after randomization, 3 months after randomization.]

    At telephone follow up at predetermined time intervals, patients were asked what their most severe level of pain they were currently experiencing as measured by the NVPS

  6. Number of patients able to ambulate post ED treatment if unable to on ED admission [Time of ED triage compared to time of ED discharge up to 24 hours after triage.]

    If patient was unable to ambulate on ED admission, did ED treatment allow ambulation without assistance: yes or no

  7. Number of patients requiring Emergency department (ED) return visits for back pain [Date of randomization to 1 day after randomization, 1 day after randomization to 1 week after randomization, 1week after randomization to 1 month after randomization, 1 month after randomization to 3 months after randomization.]

    At telephone follow up at predetermined intervals, patients were asked if they had to return subsequently to the emergency department due to their back pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Patients deemed to have mechanical back pain with a component of paravertebral tenderness or paravertebral spasm reported by the patient or noted on examination by treating physician.

Exclusion Criteria:
  • previous recipient of erector spinae plane block

  • exam concerning for cauda equina syndrome

  • current IV drug use

  • organ transplant recipient

  • history of or suspected bleeding diathesis

  • current use of anticoagulants

  • sepsis or soft tissue infection at site of the block within last three months

  • pregnancy

  • overt malignancy involving skin or underlying soft tissue at the site of block

  • allergy to any of the research medications

  • inability to participate in telephone follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nanaimo Regional General Hospital Nanaimo British Columbia Canada V9S2B7

Sponsors and Collaborators

  • Island Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ben Ho, Emergency department staff physician, Island Health
ClinicalTrials.gov Identifier:
NCT05982483
Other Study ID Numbers:
  • C2018-102
First Posted:
Aug 8, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ben Ho, Emergency department staff physician, Island Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2023